Intrapatient Variations in Type 1 Diabetes-specific iPS Cell Differentiation into Insulin-producing Cells

Tayaramma Thatava, Yogish C. Kudva, Ramakrishna Edukulla, Karen Squillace, Josep Genebriera De Lamo, Yulia Krotova Khan, Toshie Sakuma, Seiga Ohmine, Andre Terzic, Yasuhiro Ikeda

Research output: Contribution to journalArticle

65 Scopus citations

Abstract

Nuclear reprogramming of adult somatic tissue enables embryo-independent generation of autologous, patient-specific induced pluripotent stem (iPS) cells. Exploiting this emergent regenerative platform for individualized medicine applications requires the establishment of bioequivalence criteria across derived pluripotent lines and lineage-specified derivatives. Here, from individual patients with type 1 diabetes (T1D) multiple human iPS clones were produced and prospectively screened using a battery of developmental markers to assess respective differentiation propensity and proficiency in yielding functional insulin (INS)-producing progeny. Global gene expression profiles, pluripotency expression patterns, and the capacity to differentiate into SOX17-and FOXA2-positive definitive endoderm (DE)-like cells were comparable among individual iPS clones. However, notable intrapatient variation was evident upon further guided differentiation into HNF4α-and HNF1β-expressing primitive gut tube, and INS-and glucagon (GCG)-expressing islet-like cells. Differential dynamics of pluripotency-associated genes and pancreatic lineage-specifying genes underlined clonal variance. Successful generation of glucose-responsive INS-producing cells required silencing of stemness programs as well as the induction of stage-specific pancreatic transcription factors. Thus, comprehensive fingerprinting of individual clones is mandatory to secure homogenous pools amenable for diagnostic and therapeutic applications of iPS cells from patients with T1D.

Original languageEnglish (US)
Pages (from-to)228-239
Number of pages12
JournalMolecular Therapy
Volume21
Issue number1
DOIs
StatePublished - Jan 2013

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Intrapatient Variations in Type 1 Diabetes-specific iPS Cell Differentiation into Insulin-producing Cells'. Together they form a unique fingerprint.

  • Cite this

    Thatava, T., Kudva, Y. C., Edukulla, R., Squillace, K., De Lamo, J. G., Khan, Y. K., Sakuma, T., Ohmine, S., Terzic, A., & Ikeda, Y. (2013). Intrapatient Variations in Type 1 Diabetes-specific iPS Cell Differentiation into Insulin-producing Cells. Molecular Therapy, 21(1), 228-239. https://doi.org/10.1038/mt.2012.245